(Q45436993)

English

Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 December 2017

Vaccination of macaques with SIV immunogens delivered by Venezuelan equine encephalitis virus replicon particle vectors followed by a mucosal challenge with SIVsmE660. (English)

1 reference

Europe PubMed Central

14 December 2017

vector-borne disease

0 references

equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis

1 reference

based on heuristic

inferred from title

Venezuelan equine encephalitis virus

object named as

Venezuelan equine encephalitis virus

1 reference

based on heuristic

inferred from title

Ronald Swanstrom

8

object named as

Ronald Swanstrom

1 reference

Europe PubMed Central

14 December 2017

David C. Montefiori

4

object named as

David C Montefiori

1 reference

Europe PubMed Central

14 December 2017

author name string

Robert E Johnston

1

1 reference

Europe PubMed Central

14 December 2017

Philip R Johnson

2

1 reference

Europe PubMed Central

14 December 2017

Mary J Connell

3

1 reference

Europe PubMed Central

14 December 2017

Ande West

5

1 reference

Europe PubMed Central

14 December 2017

Martha L Collier

6

1 reference

Europe PubMed Central

14 December 2017

Chad Cecil

7

1 reference

Europe PubMed Central

14 December 2017

Jeffrey A Frelinger

9

1 reference

Europe PubMed Central

14 December 2017

Nancy L Davis

10

1 reference

Europe PubMed Central

14 December 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

14 December 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

14 December 2017

23

1 reference

Europe PubMed Central

14 December 2017

4969-4979

1 reference

Europe PubMed Central

14 December 2017

42

1 reference

Europe PubMed Central

14 December 2017

Vaccine protection against simian immunodeficiency virus by recombinant strains of herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protection against simian immunodeficiency virus vaginal challenge by using Sabin poliovirus vectors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Comparison of vaccine strategies using recombinant env-gag-pol MVA with or without an oligomeric Env protein boost in the SHIV rhesus macaque model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Improved protection of rhesus macaques against intrarectal simian immunodeficiency virus SIV(mac251) challenge by a replication-competent Ad5hr-SIVenv/rev and Ad5hr-SIVgag recombinant priming/gp120 boosting regimen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Vaccine-elicited immune responses prevent clinical AIDS in SHIV(89.6P)-infected rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Slowly declining levels of viral RNA and DNA in DNA/recombinant modified vaccinia virus Ankara-vaccinated macaques with controlled simian-human immunodeficiency virus SHIV-89.6P challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Cytotoxic T lymphocyte-based control of simian immunodeficiency virus replication in a preclinical AIDS vaccine trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Recombinant poxvirus boosting of DNA-primed rhesus monkeys augments peak but not memory T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Effects of in vivo CD8(+) T cell depletion on virus replication in rhesus macaques immunized with a live, attenuated simian immunodeficiency virus vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Effects of antibody on viral kinetics in simian/human immunodeficiency virus infection: implications for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Control of simian/human immunodeficiency virus viremia and disease progression after IL-2-augmented DNA-modified vaccinia virus Ankara nasal vaccination in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protective efficacy of a multicomponent vector vaccine in cynomolgus monkeys after intrarectal simian immunodeficiency virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protection against mucosal simian immunodeficiency virus SIV(mac251) challenge by using replicating adenovirus-SIV multigene vaccine priming and subunit boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

AIDS vaccine models: challenging challenge viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Role of dendritic cell targeting in Venezuelan equine encephalitis virus pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Roles of the six peptide-binding pockets of the HLA-A2 molecule in allorecognition by human cytotoxic T-cell clones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Direct and quantitative detection of HIV-1 RNA in human plasma with a branched DNA signal amplification assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Expression of the two major envelope proteins of equine arteritis virus as a heterodimer is necessary for induction of neutralizing antibodies in mice immunized with recombinant Venezuelan equine encephalitis virus replicon particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Alphavirus replicon particles expressing the two major envelope proteins of equine arteritis virus induce high level protection against challenge with virulent virus in vaccinated horses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Vaccine potential of Ebola virus VP24, VP30, VP35, and VP40 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Immune protection against staphylococcal enterotoxin-induced toxic shock by vaccination with a Venezuelan equine encephalitis virus replicon

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Venezuelan equine encephalitis virus-vectored vaccines protect mice against anthrax spore challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Blockade of T cell costimulation reveals interrelated actions of CD4+ and CD8+ T cells in control of SIV replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Enhanced SIV replication and accelerated progression to AIDS in macaques primed to mount a CD4 T cell response to the SIV envelope protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

Protection of macaques against intrarectal infection by a combination immunization regimen with recombinant simian immunodeficiency virus SIVmne gp160 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

based on heuristic

inferred from DOI database lookup

A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.05.034

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.05.034

1 reference

Europe PubMed Central

14 December 2017

1 reference

Europe PubMed Central

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45436993&oldid=1775133966"